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Abstract 26 
 27 
Objective: To quantify the influence of baseline pain levels on weight change at one-year 28 
follow-up in patients attending a National Health Service specialist weight management 29 
programme. 30 
 31 
Methods: We compared one-year follow-up weight (body mass) change between patient sub-32 
groups of none-to-mild, moderate, and severe pain at baseline. A mean sub-group difference 33 
in weight change of ≥5kg was considered clinically relevant. 34 
 35 
Results: Of the 141 complete cases, n=43 (30.5%) reported none-to-mild pain, n=44 (31.2%) 36 
reported moderate pain, and n=54 (38.3%) reported severe pain. Covariate-adjusted mean 37 
weight loss (95%CI) was similar for those with none-to-mild (8.1kg (4.2 to 12.0kg)) and 38 
moderate pain (8.3kg (4.9 to 11.7kg). The mean weight loss of 3.0kg (-0.4 to 6.4kg) for the 39 
severe pain group was 5.1kg (-0.6 to 10.7, p=0.08) lower than the none-to-mild pain group 40 
and 5.3kg (0.4 to 10.2kg, p=0.03) lower than the moderate pain group. 41 
 42 
Conclusions: Patients with severe pain upon entry to a specialist weight management service 43 
in England achieve a smaller mean weight loss at one-year follow-up than those with none-44 
to-moderate pain. The magnitude of the difference in mean weight loss was clinically 45 
relevant, highlighting the importance of addressing severe persistent pain in obese patients 46 
undertaking weight management programmes. 47 
 48 
 49 
 50 
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Introduction 51 
 52 
Obesity is a major public health issue affecting one in four adults in England (1). As such, 53 
strategies to enhance the effectiveness of weight loss services are of national importance (2) 54 
and it is essential that the weight management services that are in place are appropriate and fit 55 
for purpose. Chronic pain affects 13% of people in the UK (3). There is a substantial body of 56 
evidence demonstrating a link between obesity and chronic pain (4-15). A dose response 57 
relationship exists, with the prevalence of pain increasing with progressively higher BMI 58 
(14).  Whilst, the full extent of this relationship has yet to be explored, it is likely to be bi-59 
directional and may be underpinned by a range of mechanical, physiological, psychosocial, 60 
and behavioural mechanisms (16,17).  61 
 62 
Clinically, pain has been implicated as an important barrier to weight loss (18) and the 63 
management of obesity-related conditions such as diabetes (19). Chronic pain can have 64 
negative effects on an individual’s diet via mechanisms such as hedonic (non-hunger related) 65 
eating (11). Additionally, pain can impede physical activity (20) and activities of daily living 66 
(21), thus hindering weight loss. Chronic pain may also adversely affect an individual’s 67 
mood, which can have negative implications for weight loss via dysregulated stress systems 68 
or unhealthy lifestyles (11,22,23). However, few studies have directly investigated the impact 69 
of persistent pain on weight loss. 70 
 71 
Wachholtz et al (21) found that 83% of patients on a 4-week intensive weight loss program in 72 
the USA reported pain. Patient sex, influenced the pain and obesity relationship, with joint 73 
pain identified as a predictor of weight loss in women but not men. In a recent secondary 74 
analysis of an RCT investigating a weight loss intervention for patients with co-existing pain 75 
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and overweight/obesity 80% reported moderate or severe pain (24). Those with severe pain 76 
reported significantly less weight loss (-0.1%) compared to those with moderate (-1.9%) or 77 
no pain (-2.1%) (24). These findings support the work of Wachholtz et al (21) and 78 
demonstrate that pain may be a considerable barrier to weight loss. However, the participants 79 
in this US study were veterans, 85% of whom were male. Thus, it is unclear if these findings 80 
would generalise to patients undergoing weight management interventions within the 81 
National Health Service (NHS) in England where up to 88% of patients are female (25) and 82 
women receive 75% of bariatric surgery (1). Thus there is a need to specifically investigate 83 
the potential effect of pain on weight loss in this context. The aim of this study was to 84 
investigate the effect of persistent pain on weight loss in individuals receiving NHS specialist 85 
weight management services. 86 
 87 
 88 
Methods 89 
 90 
Participants 91 
 92 
This is an analysis of an NHS clinical dataset of patients who attended a specialist weight 93 
management service in the North East of England from February 2013 to November 2014. To 94 
be referred to the specialist weight management service patients were required to meet the 95 
following admissions criteria of having a BMI of ≥40 or a BMI ≥35 with a significant co-96 
morbidity such as diabetes or hypertension. Furthermore, patients were required to be 97 
registered with a local GP; aged ≥16years; with an ability to take charge of their dietary 98 
intake; assessed as “ready to change”; and have had previous attempts at weight loss either in 99 
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primary care including community weight management programmes, exercise programmes or 100 
anti-obesity medication for a minimum of 6 months. Their GP needed to have completed a 101 
recent metabolic and endocrine assessment and could show that the patient’s underlying 102 
endocrine diagnosis was stable and any secondary causes of obesity excluded. Patients were 103 
excluded from referral to the specialist weight management service if they did not meet the 104 
admission criteria above, or if they had a suspected or diagnosed malignancy, were pregnant, 105 
or requiring post-bariatric care (unless previously known to the service). From the pre-106 
existing patient database, to be included in this study, participants needed to have provided 107 
baseline and one-year outcome data. Response: Ethical approval for this study was obtained 108 
from The School of Health and Social Care Research Ethics and Governance Committee at 109 
Teesside University (Reference number 074/14) and the Wales 7 National Research Ethics 110 
Committee (Reference number 14/WA/1050). The IRB waived the need for individual participant 111 
consent for medical records to be used in this study, and data was accessed anonymously.  112 
 113 
 114 
Intervention 115 
 116 
The specialist weight management service provides a multidisciplinary, biopsychosocial 117 
approach for morbidly obese patients. 118 
 119 
Patient treatment programmes consist of three main phases. The timing of these phases varied 120 
from patient to patient. In phase 1, patents initially receive a multidisciplinary team (MDT) 121 
assessment including consultation with a Dietician, Physiotherapist, Psychologist, Metabolic 122 
Physician/Endocrinologist, GP with a specialist interest in obesity management, and an 123 
individual care plan is generated. The individual care plan includes: an exercise and physical 124 
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activity plan; outcomes expected for the individual; target weight; behavioural goals; 125 
modification of eating patterns; goals relating to lifestyle factors; changes in behaviour 126 
relating to triggers and barriers; food and activity diaries; tools and educational materials. In 127 
phase 2, patients move into group services and treatment according to their specific needs and 128 
care plan. During this phase a weekly drop-in and telephone support service is provided. 129 
Interactions with these elements of the service are recorded and shared with the patient’s Care 130 
Manager. In phase 3, patients are discharged from the service with details of the patient’s 131 
outcomes and an ongoing care plan sent to their GP; signposting to support groups; 132 
community weight management services and exercise groups for further weight loss and/or 133 
weight maintenance support.  134 
 135 
 136 
Outcome measures 137 
 138 
Whilst outcome measures within the specialist weight management service are collected at 139 
regular intervals this study includes only the baseline and one-year post baseline data. The 140 
primary outcome measure was weight (body mass) loss, which was measured using a 141 
weighing scales (SECA 645 hand rail scale). Height was also recorded using a Leicester 142 
Height Measure (Mark 2) so that BMI could be calculated.  143 
 144 
Pain was measured using the Short-form 36 (SF36) bodily pain subscale (26,27). The scale 145 
includes two questions 1) how much bodily pain have you had during the past four weeks? 146 
and 2) during the past four weeks, how much did pain interfere with your normal work 147 
(including work both outside the home and housework)? The first question is rated on a 6-148 
point Likert scale ranging from none to very severe, whilst the second question is rated on a 149 
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5-point Likert scale ranging from not at all to extremely. The raw score is then converted as a 150 
simple algebraic sum into a 0-100% scale value with higher scores representing higher pain 151 
levels (27). The SF36 bodily pain scale is widely used and has demonstrated good levels of 152 
validity and reliability as a measure of pain (27-29). 153 
 154 
The following additional participant characteristics were collected: sex, age, socioeconomic 155 
status and depression levels. Socioeconomic status was assessed using the Lower layer Super 156 
Output Area (LSOA) which is derived from the patient’s postcode. The LSOA was used to 157 
assign each patient an index of multiple deprivation, which was categorised into deciles with 158 
1 being least affluent and 10 being most affluent.  Depression levels were measured using the 159 
depression subscale of the Hospital Anxiety and Depression scale (HADs) (30).  160 
 161 
 162 
Statistical analysis  163 
 164 
Individuals were categorised into none-to-mild, moderate, and severe pain sub-groups 165 
according to their baseline pain scores. The cut-off points used in this analysis were <50% 166 
mild pain, 50-69.99% moderate pain, and 70-100% severe pain (31). A general linear model 167 
was used with weight loss (kg) as the dependent variable and pain subgroup as the 168 
independent variable (fixed effect). This model was covariate-adjusted for any differences in 169 
baseline weight, age, sex, socioeconomic status, and depression levels between sub-groups. 170 
Covariate-adjusted subgroup mean differences in weight loss and associated 95% confidence 171 
intervals (95%CI) were estimated for our primary comparisons.  172 
 173 
8 
 
A sub-group difference in mean weight change was considered clinically relevant if it was 174 
≥5kg. This was based upon the American Heart Association guidelines which state that 175 
reductions in weight of 2.5-5.5kg achieved through lifestyle interventions can reduce the risk 176 
of developing type 2 diabetes in overweight and obese individuals by 30-60%, while a 177 
reduction of 5-8kg can improve triglyceride levels and blood lipid profile (32). 178 
 179 
 180 
Results 181 
 182 
Data were obtained for 167 participants who provided baseline and one-year follow-up data. 183 
Of these, 26 had missing data and were thus excluded from the analysis. The descriptive 184 
characteristics for those with complete data and those with missing data are shown in Table 1. 185 
There was no substantial difference for outcome or exposure variables between those with 186 
complete and incomplete data.  187 
 188 
Table 1: Key characteristics for complete case and missing data groups. 189 
 Complete Missing 
 n=141 
 
n=26 
Age (yrs) 52.2 (11.9) 52.5 (14.6) 
Sex   
    Men 30% 31% 
    Women 70% 69% 
Socioeconomic status (1-10) 3 (1-6) 2 (1-4.5) 
Depression (0-21) 8.0 (4.4) 8.8 (4.2) 
Height (m) 1.65 (0.09) 1.65 (0.11) 
Weight (kg) 127.2 (23.0) 130.7 (25.1) 
Weight change (kg) 6.2 (11.5) 7.5 (7.5) 
Weight change (%) -4.9  -5.7 
≥5kg weight loss achieved 52% 52% 
BMI (kg.m-2) 46.3 (7.2) 47.6 (8.4) 
Pain (0-100%) 60.3 (26.9) 66.7 (24.3) 
   
Data are mean (SD) unless stated 190 
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Median and IQR is presented for socioeconomic status 191 
In the missing group column n=26 for all variables except: socioeconomic status n=14, 192 
depression n=23, weight change kg and % n=21, 5kg and 5% weight loss achieved n=21, 193 
pain n=16. 194 
 195 
Of the 141 complete cases, over the one-year period 52% of patients lost ≥5kg, which is a 196 
greater proportion than that expected due to typical within-subjects variation in weight (33). 197 
The adjusted mean weight loss for the pooled sample was 6.5kg (95% CI 4.6 to 8.4kg) 198 
equivalent to a loss of 5.1% of initial weight. The average pain levels at baseline were 60.3% 199 
(SD 26.9%). When broken down into the pain subgroups, n=43 (30.5%) reported none-to-200 
mild pain (of which n=6 reported no pain), n=44 (31.2%) reported moderate pain, and n=54 201 
(38.3%) reported severe pain.  202 
 203 
Covariate-adjusted mean weight loss (95%CI) was similar for those with none-to-mild pain 204 
(8.1kg (4.2 to 12.0kg)) and moderate pain (8.3kg (4.9 to 11.7kg)), but was lower for the 205 
severe pain group (3.0kg (-0.4 to 6.4kg)) (Figure 1). There was evidence of an effect of 206 
baseline pain levels on weight loss after adjusting for all other covariates (p=0.08). The mean 207 
difference (95%CI) in weight loss between the none-to-mild pain and the moderate pain 208 
groups was 0.2kg (-4.9 to 5.3, p=0.94). The mean difference in weight loss for the severe 209 
pain group was 5.1kg (-0.6 to 10.7, p=0.08) lower than the none-to-mild pain group and 210 
5.3kg (0.4 to 10.2, p=0.03) lower than the moderate pain group. The raw data used for the 211 
analysis can be found in supporting information (S1_appendix). 212 
Fig 1: One-year weight loss separated by pain classification group 213 
 214 
 215 
Discussion 216 
 217 
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This is the first study to directly investigate the effect of persistent pain on weight loss in 218 
patients undergoing specialist weight management within the NHS. More than 95% of the 219 
patients reported persistent pain at baseline with more than a third of patients reporting severe 220 
pain. Our findings indicate that patients with severe pain at baseline lost less weight at one-221 
year follow-up when compared to those with none-to-mild pain or moderate pain. There was 222 
no difference between the none-to-mild pain and moderate pain groups. 223 
 224 
The findings of our study are broadly in keeping with Masheb et al. (24) who found that 225 
people with severe pain lost significantly less weight -0.3kg (-1.8 to 1.2kg) than those with no 226 
pain -2.1kg (-2.7 to -1.4kg) or moderate pain -2.2kg (-3.5 to -0.09kg) and similar levels of 227 
weight loss between those with no pain and moderate pain (24). The magnitude of the weight 228 
loss in our study was greater than that seen in Masheb et al. (24) who reported a group weight 229 
loss of 1.71% with 21.9% achieving weight loss of ≥5% in comparison to our study where 230 
there was a weight loss of 5.1% and 48% of patients achieved a weight loss of ≥5%. The 231 
difference in magnitude may be related to baseline obesity levels which were higher in the 232 
current study compared to that of Masheb et al. (24) (BMI = 46 vs. 36kg.m-2). Other reasons 233 
may be to do with differences in study methodology. Masheb et al. (24) was a reanalysis of 234 
an RCT investigating the effects of a weight loss intervention compared to a control in 235 
veterans, predominantly middle-aged males (85%), while our data was from patients 236 
receiving their usual care, predominantly females (70%). The differences may also have been 237 
cultural/geographical between the US and the UK. The magnitude of the weight loss in our 238 
study is comparable to that seen in conservative weight loss programmes in other parts of the 239 
UK (-4.8kg and -4.6%) (25). 240 
 241 
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The clinical implication of our findings is that severe pain levels may be a considerable 242 
barrier to weight loss in those referred to specialist weight management services in the NHS 243 
by a magnitude of 5kg. Given the high prevalence levels of persistent pain in obese 244 
populations, especially in those with more severe obesity (14), the reach and significance of 245 
pain as a barrier to weight loss may be considerable. As such, these findings support previous 246 
calls for better integration between weight management and pain management services 247 
(12,18). Additional support may be warranted for patients with severe pain. Given that pain 248 
and its associated functional impairments are at least partly modifiable, targeting pain as part 249 
of a weight management strategy could potentially enhance weight loss outcomes for those 250 
with co-existing obesity and severe pain. There are a small but growing number of trials 251 
investigating the effectiveness of combined pain and weight management interventions in 252 
obese patients (34,35). Our findings emphasise the merit of this work and suggest that such 253 
interventions may be best targeted at those with more severe pain.  254 
 255 
This study has a number of limitations. This is a retrospective observational study, thus no 256 
claims of cause and effect can be made. While pain was measured using a valid and reliable 257 
questionnaire, pain characteristics such as location, duration and type of pain were not 258 
recorded. Thus, their potential role in weight loss was not explored. Whilst a number of 259 
important co-variates were adjusted for within the statistical model, some potentially important 260 
co-variates such as diet were not included.  During the time period in which this data was 261 
collected, 837 patients were discharged from the specialist weight management service. Thus, 262 
data was only available for 19% of the patients at this clinic. As such, this sample may not be 263 
representative of patients attending NHS weight management services, reducing the 264 
generalisability of our findings. Additionally, the sample is small, which increases the risk of 265 
a type II error. However, the strength of this work is the use of a well-validated measure of 266 
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pain and clinically established published cut-off values for none-to-mild, moderate and severe 267 
pain. Data on the location of the pain would have been useful contextual information but 268 
previous work suggests that it may be of limited relevance (24). 269 
 270 
 271 
Conclusion 272 
 273 
In conclusion, patients with severe pain at the point of entry to an NHS specialist weight 274 
management service appear to lose less weight at one-year follow-up compared to those with 275 
none-to-mild or moderate pain. The magnitude of the difference is likely to be clinically 276 
relevant and highlights the potential gains in weight loss that might be achieved by 277 
addressing concomitant persistent pain in weight management services. There was no 278 
difference in weight loss between those who reported none-to-mild pain and moderate pain. 279 
These findings broadly support earlier findings in a sample of, predominantly male, US 280 
veterans (24), thus suggesting they are applicable to the NHS, which comprises of a high 281 
proportion of female patients. Future studies need to be conducted to more firmly establish 282 
the generalisability of these findings into the wider NHS setting, including applicability in 283 
non-specialised community weight management setting, which include patients with less 284 
severe forms of obesity. Future work investigating the feasibility of incorporating some form 285 
of pain management into the weight management setting is also be warranted. 286 
 287 
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Fig 1: One-year weight loss separated by pain classification group 443 
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